Trial · NCT01092182
Adverse events1,074
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,074
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal distension | Gastrointestinal disorders | Group A - Low-risk Burkitt Lymphoma (BL) | 0 | 15 | 0 |
| other | Abdominal distension | Gastrointestinal disorders | Group B - High-Risk Burkitt Lymphoma (BL) | 3 | 98 | 3 |
| other | Abdominal distension | Gastrointestinal disorders | Group C - High-Risk Diffuse Large B Cell Lymphoma (DLBCL) | 0 | 81 | 0 |
| other | Abdominal infection | Gastrointestinal disorders | Group A - Low-risk Burkitt Lymphoma (BL) | 0 | 15 | 0 |
| other | Abdominal infection | Gastrointestinal disorders | Group B - High-Risk Burkitt Lymphoma (BL) | 2 | 98 | 2 |
| other | Abdominal infection | Gastrointestinal disorders | Group C - High-Risk Diffuse Large B Cell Lymphoma (DLBCL) | 0 | 81 | 0 |
| other | Abdominal pain | Gastrointestinal disorders | Group A - Low-risk Burkitt Lymphoma (BL) | 2 | 15 | 2 |
| other | Abdominal pain | Gastrointestinal disorders | Group B - High-Risk Burkitt Lymphoma (BL) | 8 | 98 | 11 |
| other | Abdominal pain | Gastrointestinal disorders | Group C - High-Risk Diffuse Large B Cell Lymphoma (DLBCL) | 5 | 81 | 5 |
| other | Activated partial thromboplastin time prolonged | Investigations | Group A - Low-risk Burkitt Lymphoma (BL) | 0 | 15 | 0 |
| other | Activated partial thromboplastin time prolonged | Investigations | Group B - High-Risk Burkitt Lymphoma (BL) | 0 | 98 | 0 |
| other | Activated partial thromboplastin time prolonged | Investigations | Group C - High-Risk Diffuse Large B Cell Lymphoma (DLBCL) | 2 | 81 | 2 |
| other | Acute coronary syndrome | Cardiac disorders | Group A - Low-risk Burkitt Lymphoma (BL) | 0 | 15 | 0 |
| other | Acute coronary syndrome | Cardiac disorders | Group B - High-Risk Burkitt Lymphoma (BL) | 0 | 98 | 0 |
| other | Acute coronary syndrome | Cardiac disorders | Group C - High-Risk Diffuse Large B Cell Lymphoma (DLBCL) | 1 | 81 | 1 |
| other | Acute kidney injury | Renal and urinary disorders | Group A - Low-risk Burkitt Lymphoma (BL) | 0 | 15 | 0 |
| other | Acute kidney injury | Renal and urinary disorders | Group B - High-Risk Burkitt Lymphoma (BL) | 0 | 98 | 0 |
| other | Acute kidney injury | Renal and urinary disorders | Group C - High-Risk Diffuse Large B Cell Lymphoma (DLBCL) | 2 | 81 | 2 |
| other | Adrenal insufficiency | Endocrine disorders | Group A - Low-risk Burkitt Lymphoma (BL) | 0 | 15 | 0 |
| other | Adrenal insufficiency | Endocrine disorders | Group B - High-Risk Burkitt Lymphoma (BL) | 1 | 98 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01092182/events